0 CHECKOUT
Global Genetic Testing Market 2015-2019 - Product Image

Global Genetic Testing Market 2015-2019

  • ID: 3346040
  • July 2015
  • Region: Global
  • 82 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMerieux
  • Cepheid
  • Elitech
  • Interpace Diagnostics
  • Myriad Genetics
  • MORE

About Genetic Testing
Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is used as a medical tool to determine the genetic defects associated with a particular disease. Genetic testing is also used in non-clinical applications such as paternity testing and forensics. In clinical applications, the primary focus of genetic testing is to identify the genetic reason for the cause of a disease, confirm a suspected diagnosis, prediction of future disease, to identify when an individual may pass his/her hereditary information to kids, and to predict treatment response in a patient. Genetic testing is also used to screen new-born babies, foetuses, or embryos used in vitro fertilization for genetic defects. The genetic testing market is categorized based on its applications into pharmacogenomics testing, predictive testing, prenatal and neonatal testing.

The analysts forecast the global genetic testing market to grow at a CAGR of 9.65% over the period 2014-2019.

Covered in this Report
The report includes the present scenario and the growth prospects READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMerieux
  • Cepheid
  • Elitech
  • Interpace Diagnostics
  • Myriad Genetics
  • MORE

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
08. Regulation of Genetic Testing
09. DTC Genetic Testing
09.1.1 Advantages and Disadvantages of DTC Genetic Testing
09.1.2 Regulation of DTC Genetic Testing
10. Geographical Segmentation
10.1 Genetic Testing Market in Americas
10.1.1 Market Size and Forecast
10.2 Genetic Testing Market in EMEA
10.2.1 Market Size and Forecast
10.3 Genetic Testing Market in APAC
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Bio-Rad Laboratories
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue by Business Segmentation
19.2.6 Revenue Comparison 2011 and 2012
19.2.7 Revenue by Geographical Segmentation
19.2.8 Key Information
19.2.9 SWOT Analysis
19.3 Qiagen
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Product Segmentation by Revenue 2013
19.3.4 Product Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Quest Diagnostics
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2011-2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Roche Diagnostics
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2014
19.5.4 Business Segmentation by Revenue 2013 and 2014
19.5.5 Geographical Segmentation by Revenue 2014
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Genetic Testing Market 2014-2019 ($ millions)
Exhibit 3: Evolution of Genetic Testing Segments
Exhibit 4: Segmentation of Global Genetic Testing Market by Application
Exhibit 5: Regulation of Genetic Testing in US
Exhibit 6: Global Genetic Testing Market by Geography 2014
Exhibit 7: Genetic Testing Market in Americas 2014-2019 ($ millions)
Exhibit 8: Genetic Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 9: Genetic Testing Market in APAC 2014-2019 ($ millions)
Exhibit 10: Segmentation of Genetic Testing Market Segmentation by Geography ($ millions)
Exhibit 11: Segmentation of Genetic Testing Market Segmentation by Geography (%)
Exhibit 12: Abbott Laboratories: Key Takeaways
Exhibit 13: Bio-Rad Laboratories: Key Takeaways
Exhibit 14: Qiagen: Key Takeaways
Exhibit 15: Quest Diagnostics: Key Takeaways
Exhibit 16: Roche Diagnostics: Key Takeaways
Exhibit 17: Abbott Laboratories: Business Segmentation
Exhibit 18: Abbott Laboratories: Revenue by Business Segmentation 2012
Exhibit 19: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 20: Abbott Laboratories: Revenue by Geographical Segmentation 2012
Exhibit 21: Bio-Rad Laboratories: Business Segmentation
Exhibit 22: Bio-Rad Laboratories: Revenue by Business Segmentation 2012
Exhibit 23: Bio-Rad Laboratories: Revenue Comparison by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 24: Bio-Rad Laboratories: Revenue by Geographical Segmentation 2012
Exhibit 25: Qiagen: Product Segmentation by Revenue 2013
Exhibit 26: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 27: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 28: Global Genetic Testing Market: Business Segmentation by Revenue 2013
Exhibit 29: Global Genetic Testing Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 30: Global Genetic Testing Market: Geographical Segmentation by Revenue 2013
Exhibit 31: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 33: Roche Diagnostics: Geographical Segmentation by Revenue 2014

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMerieux
  • Cepheid
  • Elitech
  • Interpace Diagnostics
  • Myriad Genetics
  • MORE

The author Announces the Publication of its Research Report – Global Genetic Testing Market 2015-2019

The author recognizes the following companies as the key players in the Global Genetic Testing Market: Abbott Laboratories, BioRad Laboratories, Qiagen, Quest Diagnostics and Roche Diagnostics

Other Prominent Vendors in the market are: Biocartis, BioMerieux, Cepheid, EKF Diagnostics, Elitech, IntegraGen, Interpace Diagnostics, Luminex, Myriad Genetics, PerkinElmer, Seegene and WaferGen Biosystems

Commenting on the report, an analyst from the team said: “According to the US National Academy of Sciences, personalized medicine is the use of genomic, epigenomic, and other data to determine individual patterns of disease, that can potentially lead to better individual treatment. Consumers who are not benefiting from general medicine can undergo personalized treatment based on a study of their genomic sequence. Personalized medicine uses molecular markers to identify disease risk or occurrence before the appearance of clinical symptoms. It also offers the chance to focus on prevention and early treatment rather than on reaction to the advanced stages of a disease. For instance, in breast cancer, BRCA1 and BRCA2 genetic tests are used to guide preventive measures. With the completion of the human genome project and advances in genomics, proteomics, and metabolomics, consumers are moving toward personalized medicine. Thus, growing demand for personalized medicine will have a positive impact on the market.”

According to the report, Down’s syndrome, sickle cell anemia, and cystic fibrosis are some of the genetic disorders caused by the presence of a gene mutation. According to the World Health Organization, the global prevalence of all single-gene diseases at birth is approximately 10 per 1,000 births. Sickle cell anemia is one of the examples of a genetic disease that affects millions worldwide. In the US alone, it affects around 72,000 people every year, and over 300,000 babies with severe hemoglobin disorders are born each year. Thus, the rise in the incidence of genetic diseases will drive the global genetic testing market.

Further, the report states that the high cost of various genetic tests may act as a hindrance to the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown
4 of 5

- Abbott Laboratories
- BioRad Laboratories
- Qiagen
- Quest Diagnostics
- Roche Diagnostics
- Biocartis
- BioMerieux
- Cepheid
- EKF Diagnostics
- Elitech
- IntegraGen
- Interpace Diagnostics
- Luminex
- Myriad Genetics
- PerkinElmer
- Seegene
- WaferGen Biosystems

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • bioCSL
  • Abbott Laboratories Ltd.
  • Radiometer Limited
  • Genfit
  • Focus Diagnostics Inc.
  • Genomic Health Inc.